Célia Margarida dos Santos Cabral
AuthID: R-000-3MT
21
TITLE: Hybrid azole-based conjugates as upcoming anticancer and antimicrobial agents
AUTHORS: Luís M T Frija; Bruno E C Guerreiro; Inês C C Costa; Vera M S Isca; Lucília Saraiva; Beatriz G Neves; Mariana Magalhães; Célia Cabral; Maria L S Cristiano ; Patrícia Rijo ;
PUBLISHED: 2023, SOURCE: Exploration of Drug Science
AUTHORS: Luís M T Frija; Bruno E C Guerreiro; Inês C C Costa; Vera M S Isca; Lucília Saraiva; Beatriz G Neves; Mariana Magalhães; Célia Cabral; Maria L S Cristiano ; Patrícia Rijo ;
PUBLISHED: 2023, SOURCE: Exploration of Drug Science
22
TITLE: New Insights into Glioblastoma. Diagnosis, Therapeutics and Theranostics
AUTHORS: Carla Vitorino; Carmen Balaña Quintero; Célia Cabral;
PUBLISHED: 2023
AUTHORS: Carla Vitorino; Carmen Balaña Quintero; Célia Cabral;
PUBLISHED: 2023
INDEXED IN: 
Openlibrary
Openlibrary23
TITLE: Nanotechnology-Based Topical Delivery of Natural Products for the Management of Atopic Dermatitis Full Text
AUTHORS: Mário Pedro Marques; Carla Varela; Laura Mendonça; Célia Cabral;
PUBLISHED: 2023, SOURCE: Pharmaceutics, VOLUME: 15, ISSUE: 6
AUTHORS: Mário Pedro Marques; Carla Varela; Laura Mendonça; Célia Cabral;
PUBLISHED: 2023, SOURCE: Pharmaceutics, VOLUME: 15, ISSUE: 6
24
TITLE: The Role of Glucosinolates from Cruciferous Vegetables (Brassicaceae) in Gastrointestinal Cancers: From Prevention to Therapeutics
AUTHORS: Melim, C; Lauro, MR; Pires, IM; Oliveira, PJ ; Cabral, C;
PUBLISHED: 2022, SOURCE: Pharmaceutics in PHARMACEUTICS, VOLUME: 14, ISSUE: 1
AUTHORS: Melim, C; Lauro, MR; Pires, IM; Oliveira, PJ ; Cabral, C;
PUBLISHED: 2022, SOURCE: Pharmaceutics in PHARMACEUTICS, VOLUME: 14, ISSUE: 1
25
TITLE: Nanoparticles as phytochemical carriers for cancer treatment: News of the last decade
AUTHORS: Melim, C; Magalhaes, M; Santos, AC; Campos, EJ; Cabral, C;
PUBLISHED: 2022, SOURCE: EXPERT OPINION ON DRUG DELIVERY, VOLUME: 19, ISSUE: 2
AUTHORS: Melim, C; Magalhaes, M; Santos, AC; Campos, EJ; Cabral, C;
PUBLISHED: 2022, SOURCE: EXPERT OPINION ON DRUG DELIVERY, VOLUME: 19, ISSUE: 2
26
TITLE: Phytochemical Study and Antiglioblastoma Activity Assessment of Plectranthus hadiensis (Forssk.) Schweinf. ex Sprenger var. hadiensis Stems Full Text
AUTHORS: Dominguez Martin, Eva Maria; Magalhaes, Mariana; Diaz Lanza, Ana Maria; Marques, Mario P.; Princiotto, Salvatore; Gomez, Ana M.; Efferth, Thomas; Cabral, Celia; Rijo, Patricia ;
PUBLISHED: 2022, SOURCE: MOLECULES, VOLUME: 27, ISSUE: 12
AUTHORS: Dominguez Martin, Eva Maria; Magalhaes, Mariana; Diaz Lanza, Ana Maria; Marques, Mario P.; Princiotto, Salvatore; Gomez, Ana M.; Efferth, Thomas; Cabral, Celia; Rijo, Patricia ;
PUBLISHED: 2022, SOURCE: MOLECULES, VOLUME: 27, ISSUE: 12
27
TITLE: Potential of Coa Valley (Portugal) plants extracts in cell model for hepatic lipid toxicity Full Text
AUTHORS: Melim, C.; Teixeira, J.; Varela, C.; Marques, M. P.; Sardao, V. A.; Oliveira, P. J.; Cabral, C.;
PUBLISHED: 2022, SOURCE: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, VOLUME: 52
AUTHORS: Melim, C.; Teixeira, J.; Varela, C.; Marques, M. P.; Sardao, V. A.; Oliveira, P. J.; Cabral, C.;
PUBLISHED: 2022, SOURCE: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, VOLUME: 52
INDEXED IN: 
WOS
WOS IN MY: 
ORCID
ORCID28
TITLE: Cytotoxic effect of ridolfia Segetum (L.) moris essential oil against glioblastoma cells Full Text
AUTHORS: Rosa, M.; Delgado, J.; Marques, M. P.; Goncalves, A. C.; Magalhaes, M.; Cabral, C.;
PUBLISHED: 2022, SOURCE: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, VOLUME: 52
AUTHORS: Rosa, M.; Delgado, J.; Marques, M. P.; Goncalves, A. C.; Magalhaes, M.; Cabral, C.;
PUBLISHED: 2022, SOURCE: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, VOLUME: 52
INDEXED IN: WOS
WOS IN MY: ORCID
ORCID29
TITLE: In vitro cardioprotective potential of Coa Valley (Portugal) plants extracts against lipotoxic insults Full Text
AUTHORS: Ilina, V.; Teixeira, J.; Varela, C.; Marques, M. P.; Sardao, V. A.; Melim, C.; Baranenko, D.; Oliveira, P. J.; Cabral, C.;
PUBLISHED: 2022, SOURCE: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, VOLUME: 52
AUTHORS: Ilina, V.; Teixeira, J.; Varela, C.; Marques, M. P.; Sardao, V. A.; Melim, C.; Baranenko, D.; Oliveira, P. J.; Cabral, C.;
PUBLISHED: 2022, SOURCE: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, VOLUME: 52
INDEXED IN: WOS
WOS IN MY: ORCID
ORCID30
TITLE: Parvifloron D-based therapy for glioblastoma: targeting tumor microenvironment with a natural drug lead Full Text
AUTHORS: Magalhaes, M.; Dominguez Martin, E. M.; Jorge, J.; Goncalves, A. C.; Diaz Lanza, A. M.; Manadas, B.; Efferth, T.; Rijo, P. ; Cabral, C.;
PUBLISHED: 2022, SOURCE: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, VOLUME: 52
AUTHORS: Magalhaes, M.; Dominguez Martin, E. M.; Jorge, J.; Goncalves, A. C.; Diaz Lanza, A. M.; Manadas, B.; Efferth, T.; Rijo, P. ; Cabral, C.;
PUBLISHED: 2022, SOURCE: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, VOLUME: 52
INDEXED IN: WOS
WOS IN MY: ORCID
ORCID